DNAGinkgo Bioworks Holdings Inc - Ordinary Shares - Class A
$7.88
$0.01
(0.13%)
Overnight
EarningsAug 6
Mkt Cap$493.2M
Vol704,069.00
Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think
Palantir (NASDAQ: PLTR) and Ginkgo Bioworks (NYSE: DNA) sit on opposite sides of a fast-emerging biosecurity debate. Palantir represents the intelligence layer, while Ginkgo represents the biological infrastructure layer. The question is whether future value comes from identifyin...
Nasdaq News: Markets
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings...
PR Newswire
The $59B Quiet Shift Reshaping How Patients Access Care
The $59B Quiet Shift Reshaping How Patients Access Care The $59B Quiet Shift Reshaping How Patients Access Care PR Newswire VANCOUVER, BC, May 12, 2026 Issued on behalf of VentriPoint Diagnostics...
PR Newswire
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab Ginkgo Bioworks Reports First Quarter 2026 Financial Results...
PR Newswire
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 11.1% - What's Next?
Ginkgo Bioworks (NYSE:DNA) Trading Up 11.1% - What's Next...
MarketBeat
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation PR Newswire BOSTON, April 30, 2026 Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026BOSTON, April 30, 2026 /PRNewswire...
PR Newswire
Ginkgo Bioworks (DNA) Projected to Post Quarterly Earnings on Tuesday
Ginkgo Bioworks (NYSE:DNA) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 6.9% Higher - Here's What Happened
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 6.9% - Still a Buy...
MarketBeat
Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Decreases By 23.2%
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totaling 6,146,646 shares, a...
MarketBeat
Ginkgo Bioworks (NYSE:DNA) Insider Sells $212,626.11 in Stock
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) insider Steven Coen sold 33,171 shares of Ginkgo Bioworks stock in a transaction on Monday, April 13th. The stock was sold at an average price of $6.41, for a total value of $212,626.11. Following the completion of the sale, the insider...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest DNA News
ViewPalantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think
Nasdaq News: Markets
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
PR Newswire
The $59B Quiet Shift Reshaping How Patients Access Care
PR Newswire
Advertisement|Remove ads.